Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

“We’ve built a unique toolbox that allows us to do macrophage drug discovery in a way that others just can’t. Our ambition is to become a global leader in this space, and ultimately take ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger ...

resulting in compounds that more efficiently fill three-dimensional molecular space and better modulate the functions of specific target proteins. Chief among these methods are DNA-encoded chemistry ...

This could open uncharted regions of chemical space in drug discovery." According to Sharma, this skeletal editing process allows for more drug diversity, because rather than developing new drugs ...

We recently compiled a list of the Blackrock’s 30 Most Important AI Stocks. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against the other ...

in artificial intelligence-backed drug discovery with news of a new partnership ... It’s AMD’s first investment in the healthcare space, which is already a target of market leader Nvidia.

However, one additional interest that is perhaps less well-known is the company’s significant investments in the world of biology and drug discovery. Among the most important aspects of this ...